MEDICAL group Boston Scientific is investing €26m in research and development at its facility in Clonmel, Co Tipperary.
The new funds will enable Boston Scientific to expand its R&D and technical capabilities regarding the design of its next-generation cardiac rhythm management devices manufactured at the Clonmel facility.